 |
| CrossRef Text and Data Mining |
| Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
| Can antioxidants be effective therapeutics for type 2 diabetes? |
| Soyoung Park, So-Young Park |
|
J Yeungnam Med Sci. 2021;38(2):83-94. Published online October 8, 2020 DOI: https://doi.org/10.12701/yujm.2020.00563 |
|
Can antioxidants be effective therapeutics for type 2 diabetes? Yeungnam University Journal of Medicine. 2021;38(2):83-94  Effective Postprandial Glucose Management in Pregnancy with Type 1 Diabetes Diabetes Technology & Therapeutics. 2016;18(6):343-345 Liraglutide Effective in the Severely Insulin-Resistant Patient with Type 2 Diabetes Requiring U-500 Insulin: A Case Report Diabetes Technology & Therapeutics. 2013;15(4):342-343 Effects of Cocoa Antioxidants in Type 2 Diabetes Mellitus Antioxidants. 2017;6(4):84 Assessing the Role of Biphasic Insulin Aspart 30 as an Effective and Tolerable Front-Line Therapy for Type 2 Diabetes Clinical Therapeutics. 2005;27:S39-S41 Oxidative Stress in Preretinopathic Diabetes Subjects and Antioxidants Diabetes Technology & Therapeutics. 2012;14(3):257-263 Oxidative Stress and Obesity- and Type 2 Diabetes-Induced Heart Failure Antioxidants. 2020;9(8):653 “Learning” Can Improve the Blood Glucose Control Performance for Type 1 Diabetes Mellitus Diabetes Technology & Therapeutics. 2017;19(1):41-48 Rate of Hypoglycemia in Insulin-Treated Patients with Type 2 Diabetes Can Be Predicted from Glycemic Variability Data Diabetes Technology & Therapeutics. 2012;14(11):1008-1012 Nateglinide and Acarbose Are Comparably Effective Reducers of Postprandial Glycemic Excursions in Chinese Antihyperglycemic Agent–Naive Subjects with Type 2 Diabetes Diabetes Technology & Therapeutics. 2013;15(6):481-488 |
